Evidence map›Paper›PMID 32111823›Full record

ArticleNature communications2020

Genome-wide association and multi-omic analyses reveal ACTN2 as a gene linked to heart failure.

Marios Arvanitis, Emmanouil Tampakakis, Yanxiao Zhang, Wei Wang, Adam Auton, 23andMe Research Team, Diptavo Dutta, Stephanie Glavaris, Ali Keramati, Nilanjan Chatterjee and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. A transcriptional enhancer regulates cardiac maturation.Nature cardiovascular research · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Marios ArvanitisDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
Emmanouil TampakakisDepartment of Medicine, Division of Cardiology, Johns Hopkins University, Baltimore, MD, USA.
Yanxiao ZhangLudwig Institute for Cancer Research, San Diego, CA, USA.ORCID http://orcid.org/0000-0001-9618-637X
Wei Wang23andMe, Inc., Mountain View, CA, USA.
Adam Auton23andMe, Inc., Mountain View, CA, USA.
23andMe Research Team
Diptavo DuttaDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-6634-9040
Stephanie GlavarisDepartment of Medicine, Division of Cardiology, Johns Hopkins University, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-8695-052X
Ali KeramatiDepartment of Medicine, Division of Cardiology, Johns Hopkins University, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-8728-1508
Nilanjan ChatterjeeDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Neil C ChiDepartment of Medicine, Division of Cardiology, University of California, San Diego, La Jolla, CA, 92093, USA.ORCID http://orcid.org/0000-0003-2324-3796
Bing RenLudwig Institute for Cancer Research, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-5435-1127
Wendy S PostDepartment of Medicine, Division of Cardiology, Johns Hopkins University, Baltimore, MD, USA.
Alexis BattleDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA. ajbattle@jhu.edu.ORCID http://orcid.org/0000-0002-5287-627X
23andMe (United States) · USJohns Hopkins University · USUniversity of California San Diego · USLudwig Cancer Research · US

Funding

PATHOPHYSIOLOGY OF MYOCARDIAL DISEASEST32HL007227 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Chulan Kwon, WENDY S POST · 1985 to 2026
$21.2M
Robust Methods for Polygenic Analysis to Inform Disease Etiology and Enhance Risk PredictionR01HG010480 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI CHATTERJEE, NILANJAN · 2019 to 2023
$2.8M
Engineering a power switch to study the contribution of stem cell-derived cardiomyocytes on heart regenerationK08HL145135 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI TAMPAKAKIS, EMMANOUIL · 2019 to 2023
$859k
American Heart Association (American Heart Association, Inc.) 19CDA34660077NHGRI NIH HHS R01 HG010480NHLBI NIH HHS K08 HL145135NHLBI NIH HHS T32 HL007227U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) K08- HL145135-01U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) T32-HL007227U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) R01-HG010480-01
6 · The paper itself

Abstract

Heart failure is a major public health problem affecting over 23 million people worldwide. In this study, we present the results of a large scale meta-analysis of heart failure GWAS and replication in a comparable sized cohort to identify one known and two novel loci associated with heart failure. Heart failure sub-phenotyping shows that a new locus in chromosome 1 is associated with left ventricular adverse remodeling and clinical heart failure, in response to different initial cardiac muscle insults. Functional characterization and fine-mapping of that locus reveal a putative causal variant in a cardiac muscle specific regulatory region activated during cardiomyocyte differentiation that binds to the ACTN2 gene, a crucial structural protein inside the cardiac sarcolemma (Hi-C interaction p-value = 0.00002). Genome-editing in human embryonic stem cell-derived cardiomyocytes confirms the influence of the identified regulatory region in the expression of ACTN2. Our findings extend our understanding of biological mechanisms underlying heart failure.

Indexed as

ABO Blood-Group SystemActininAtrial FibrillationChromosomes, Human, Pair 1Enhancer Elements, GeneticGene Expression RegulationGenetic Predisposition to DiseaseGenome-Wide Association StudyHeart FailureHuman Embryonic Stem CellsHumansMusculoskeletal DiseasesMyocytes, CardiacPolymorphism, Single NucleotideQuantitative Trait LociABO Blood-Group SystemActininACTN2 protein, human

Identifiers

PMID32111823
PMCPMC7048760
OpenAlexW3010597276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.